Study to Evaluate Tezepelumab in Adults With Severe Uncontrolled Asthma
Clinical trial NCT03927157 · COMPLETED
Trial details
- NCT number
- NCT03927157
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-14
- Primary completion
- 2024-05-24
- Enrollment
- 405
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.